本页面由Tiger Trade Technology Pte. Ltd.提供服务

CG Oncology Inc.

78.23
-1.5800-1.98%
盘后78.230.00000.00%16:53 EDT
成交量:116.26万
成交额:9,122.31万
市值:69.34亿
市盈率:-28.72
高:79.89
开:79.44
低:77.51
收:79.81
52周最高:80.97
52周最低:25.25
股本:8,864.04万
流通股本:6,473.22万
量比:1.56
换手率:1.80%
股息:- -
股息率:- -
每股收益(TTM):-2.7235
每股收益(LYR):-2.0826
净资产收益率:-26.41%
总资产收益率:-17.67%
市净率:6.74
市盈率(LYR):-37.56

数据加载中...

2026/08/20

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/08/17

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/08/14

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/08/14

超过5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/08/14

超过5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/08/13

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/08/13

超过5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/08/12

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/08/11

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/08/10

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/08/07

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/08/07

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/08/06

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/08/06

重要事件披露

Form 8-K - Current report
2026/08/05

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/07/30

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/07/29

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/07/28

超过5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/07/28

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/07/24

关联方拟减持公告

Form 144 - Report of proposed sale of securities